EDGAR Filing Documents for 0001564590-19-004252

Form 8-K - Current report:

SEC Accession No. 0001564590-19-004252

Filing Date

2019-02-26

Accepted

2019-02-26 07:36:10

Documents

Period of Report

2019-02-26

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K - R&D DAY	ctmx-8k_20190226.htm	8-K	30671
2	EX-99.1	ctmx-ex991_23.htm	EX-99.1	54116
3	GRAPHIC	gf0an0bozisx000001.jpg	GRAPHIC	8098
	Complete submission text file	0001564590-19-004252.txt		97210

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 19631648
SIC: 2834 Pharmaceutical Preparations